Busisiwe Beko, from Khayelitsha in the Western Cape, was diagnosed with drug-resistant tuberculosis (DR-TB) while she was pregnant. She remembers it as a very difficult period in her life.

RESIST-TB released its November 2022 newsletter with the latest research publications on drug-resistant TB.

The TB Vaccine Advocacy Roadmap (TB Vax ARM) and the Stop TB Partnership Working Group on New TB Vaccines announced a new advocacy fellowship program, set to take place in February 2023 in the run up to World TB Day. The program will convene six fellows representing TB affected communities, advocates, and early career researchers from high TB burden countries for an online skill building and co-learning program. The goal of the program is to help cultivate a new generation of TB vaccine R&D advocates and stimulate more diverse advocacy efforts for TB vaccine R&D ahead of the UN High-Level Meeting on TB in September 2023 and beyond.

Public Health Action is the peer-reviewed open access journal of The International Union Against Tuberculosis and Lung Disease. It communicates and reports new knowledge across all relevant areas of operational research including: infection control, nutrition, TB, HIV, vaccines, smoking, COVID-19, microbial resistance and disease outbreaks.

On the 3^rd of December every year, the world observes the International Day of Persons with Disabilities. This day aims to promote better understanding of issues faced by people with disabilities, and to mobilize support for their dignity, rights and well-being. This year’s theme “Transformative solutions for inclusive development: the role of innovation in fuelling an accessible and equitable world” calls for actions to tackle challenges affecting the lives of persons with disabilities through innovation and technology solutions for inclusive development.

The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).

Scientists studying how a common tuberculosis vaccine works have discovered that it induces a previously unknown mechanism in the gut that triggers a systemic immune alert, which then causes changes in the innate immune system in the lung to fend off not just tuberculosis, but a broad range of respiratory pathogens.

Imagine the scenario: you’ve been told you have a disease that will kill you. But, the doctor adds, your life can be saved if you diligently take your medication. Don’t skip a day, don’t skip a dosage. Soon, however, you discover that the medication has a slew of side effects, including a loss of appetite, fatigue, and nausea. So you do stop.

In 2021, an estimated 10.6 million individuals developed tuberculosis (TB) and 1.6 million died, making it the second most lethal infection in the world after SARS-CoV-2. Undernutrition, a deficiency of macronutrients and micronutrients, is the leading risk factor for TB globally, however its impact on treatment outcomes is poorly defined.

The World Health Organization is joining partners in commemorating World AIDS Day 2022, and calls on global leaders and citizens to equalize access to essential HIV and TB services, particularly for key and vulnerable populations.